EU regulators give nod to AstraZeneca COVID vaccine for emergency use

The European Medicines Agency (EMA) today recommended the AstraZeneca-Oxford vaccine for emergency use in European Union (EU) countries, which came with more details about efficacy, which is about 60%, with the vaccine showing good impact against severe disease. The approval shed more light on findings from phase 3 clinical trials in the United Kingdom, Brazil, and South Africa and comes amid a row between EU officials and the company over supply contracts, which followed an announcement from the company that its supply would be less than expected.